https://allsci.com/news/biotech/sbma-treatment-annji-advances-aj201-into-phase/ AllScien 2026-10-05T09:24:34.428944Z AnnJi advances androgen receptor-clearing rosolutamide into Phase III for Kennedy’s disease https://allsci.com/news/biotech/tre-515-fast-track-fda-grants-designation-kras/ AllScien 2026-10-05T08:59:51.897575Z Trethera wins Fast Track for dCK inhibitor TRE-515 in KRAS G12C lung cancer combination https://allsci.com/news/clinical-trials/cutaneous-lupus-biogens-litifilimab-shows/ AllScien 2026-10-05T08:21:32.038745Z Biogen’s litifilimab builds momentum with durable 52-week responses in CLE